Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carrots and Stick: Biopharma At The White House

Executive Summary

Drug industry executives discuss drug pricing and tax and regulatory reform in a high-profile meeting with President Trump at the White House.

Advertisement

Related Content

Trump Lauds Big Pharma Collaboration On Super Strong Glass Packaging
Biotech Execs Promote Biomedical R&D At White House Meeting
Scientists Marched To Protect NIH Grants, But Where Was Pharma?
PhRMA Uses Allergan Stage In Campaign To Keep Focus On Industry's Reputation For Innovation
Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent
Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent
Stockwatch: Pfizer, Roche, AZ, Novo Prolong Pharmaceutical Winter
CEOs Tell Trump Tax Cuts Could Bring More Biopharma Plants To US
Trump’s Drug Pricing Remarks: A Gambit For Industry Self-Restraint?
Pharma Is Ready And Waiting For A Tax Holiday Under Trump

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC098149

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel